Simplified cardiovascular index may be the best comorbidity index for clinical use in prediction of mortality for renal cancer patients

CONCLUSION: Increasing comorbidity, age, tumor size, and cM stage are predictors of ACM for suspected renal cancer patients. CVI appears to provide comparable information to various iterations of CCI (uCCI, aCCI) while being the simplest to use. Utilization of CVI may assist clinicians and patients when considering between interventional and noninterventional approaches for suspected renal cancer.PMID:38242826 | DOI:10.1016/j.urolonc.2024.01.004

Source: Urologic Oncology - January 19, 2024 Category: Urology & Nephrology Authors: Dennis Boynton Sabrina L Noyes Adharsh Murali Henry Peabody Andrew Krumm Karandeep Singh Brian R Lane Source Type: research